iconoclast:
"Hepalink filed their IPO document with the HK stock exchange. Much of what they write about RVX is well known to us. Hepalink says they own 38.8% of RVX; I was under the impression that they were north of 40%."
I believe the IPO they are issuing relates to OncoQuest and not Resverlogix, an Antibody-based Immuno-oncology, ovarian cancer.
IMO .... Koo